GGrantIndex
← Leaderboards

Maarten C Bosland

New York University School Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗
$10,491,195
Attributed
$10,491,195
Total exposure
17
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY2005–12
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$10,491,195 · 17

By mechanism

R01$5,583,448 · 5
P30$2,660,693 · 2
U01$749,847 · 1
G20$630,000 · 1
R21$370,501 · 1
R03$314,000 · 2

Top collaborators

No co-investigators on record.

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Chemoprevention”

Research focus

ChemopreventionMalignant Neoplasm Of ProstateMalignant NeoplasmsEstradiolTestosteroneProstateSourceDoseCancer PreventionAnimal ModelFundingPreventOxidative StressProstate NeoplasmsMonitorGenisteinEpidemiologic StudiesCancer RiskBiologicalProstatic Intraepithelial NeoplasiasChemopreventive AgentProtective EffectFutureCarcinogenesis

Grant awards (57)

Effects of SOD2 genotype, oxidative stress, ER??, and genistein on prostate cance$78,500
R03 · FY2012 · CA · contact PI
Preventive Activity of Black Raspberries against Prostate Cancer$165,616
R21 · FY2011 · CA · contact PI
Effects of SOD2 genotype, oxidative stress, ER??, and genistein on prostate cance$78,500
R03 · FY2011 · CA · contact PI
Expirimental Animal Services Core$288,325
P30 · FY2010 · ES · contact PI
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY$251,751
R01 · FY2010 · CA · contact PI
Preventive Activity of Black Raspberries against Prostate Cancer$204,885
R21 · FY2010 · CA · contact PI
Hormonal Induction Mouse Models of Prostate Cancer$78,500
R03 · FY2010 · CA · contact PI
Expirimental Animal Services Core$287,790
P30 · FY2009 · ES · contact PI
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY$245,369
R01 · FY2009 · CA · contact PI
Hormonal Induction Mouse Models of Prostate Cancer$78,500
R03 · FY2009 · CA · contact PI
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY$321,017
R01 · FY2008 · CA · contact PI
Expirimental Animal Services Core$285,527
P30 · FY2008 · ES · contact PI
PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS$244,138
R01 · FY2008 · CA · contact PI
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY$86,800
R01 · FY2008 · CA · contact PI
CLINICAL TRIAL: PROSTATE CANCER CHEMOPREVENTION TRIAL$9,613
M01 · FY2008 · RR · contact PI
PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS$262,798
R01 · FY2007 · CA · contact PI
PHASE II TRIAL OF SOY PRIOR TO RADICAL PROSTATECTOMY$258,582
R01 · FY2007 · CA · contact PI
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY$243,068
R01 · FY2007 · CA · contact PI
Expirimental Animal Services Core$239,643
P30 · FY2007 · ES · contact PI
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY$86,800
R01 · FY2007 · CA · contact PI
PROSTATE CANCER CHEMOPREVENTION TRIAL$33,929
M01 · FY2007 · RR · contact PI
PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS$33,187
R01 · FY2007 · CA · contact PI
2003 Hormonal Carcinogenesis Gordon Research Conference$11,000
R13 · FY2007 · CA · contact PI
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY$285,577
R01 · FY2006 · CA · contact PI
Expirimental Animal Services Core$273,162
P30 · FY2006 · ES · contact PI
PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS$270,647
R01 · FY2006 · CA · contact PI
PHASE II TRIAL OF SOY PRIOR TO RADICAL PROSTATECTOMY$260,714
R01 · FY2006 · CA · contact PI
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY$125,490
R01 · FY2006 · CA · contact PI
PHASE II TRIAL OF SOY PRIOR TO RADICAL PROSTATECTOMY$69,005
R01 · FY2006 · CA · contact PI
PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS$64,639
R01 · FY2006 · CA · contact PI
PROSTATE CANCER CHEMOPREVENTION TRIAL$29,927
M01 · FY2006 · RR · contact PI
PHASE II TRIAL OF SOY PRIOR TO RADICAL PROSTATECTOMY$366,774
R01 · FY2005 · CA
PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS$277,160
R01 · FY2005 · CA
PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS$31,476
R01 · FY2005 · CA
PROSTATE CANCER CHEMOPREVENTION TRIAL$28,647
M01 · FY2005 · RR
2003 Hormonal Carcinogenesis Gordon Research Conference$12,000
R13 · FY2005 · CA
IMPROVING ENVIRONMENTAL QUALITY AND HAZARD CONTAINMENT$630,000
G20 · FY2004 · RR
PHASE II TRIAL OF SOY PRIOR TO RADICAL PROSTATECTOMY$347,594
R01 · FY2004 · CA
PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS$277,160
R01 · FY2004 · CA
Prostate Cancer Chemoprevention Trial$36,584
M01 · FY2004 · RR
HORMONAL INDUCTION ANIMAL MODEL OF PROSTATE CANCER$256,229
R01 · FY2002 · CA
Core--Histopathology &experimental animal services$228,547
P30 · FY2002 · ES
Core--Histopathology &experimental animal services$228,547
P30 · FY2002 · ES
PROSTATE CANCER CHEMOPREVENTION TRIAL$0
M01 · FY2002 · RR
PROSTATE CANCER CHEMOPREVENTION CLINICAL TRIALS$331,604
U01 · FY2001 · CA
HORMONAL INDUCTION ANIMAL MODEL OF PROSTATE CANCER$249,119
R01 · FY2001 · CA
Core--Histopathology &experimental animal services$228,547
P30 · FY2001 · ES
Core--Histopathology &experimental animal services$228,547
P30 · FY2001 · ES
Core--Histopathology &experimental animal services$118,905
P30 · FY2001 · ES
PROSTATE CANCER CHEMOPREVENTION TRIAL$0
M01 · FY2001 · RR
PROSTATE CANCER CHEMOPREVENTION CLINICAL TRIALS$418,243
U01 · FY2000 · CA
PRECLINICAL PROSTATE CANCER CHEMOPREVENTION STUDIES$359,911
R01 · FY2000 · CA
HORMONAL INDUCTION ANIMAL MODEL OF PROSTATE CANCER$308,443
R01 · FY2000 · CA
CORE--HISTOPATHOLOGY AND EXPERIMENTAL ANIMAL FACILITY$134,248
P30 · FY2000 · CA
Core--Histopathology &experimental animal services$118,905
P30 · FY2000 · ES
PROSTATE CANCER CHEMOPREVENTION TRIAL$21,006
M01 · FY2000 · RR
PROSTATE CANCER CHEMOPREVENTION TRIAL$0
M01 · FY2000 · RR